"U.S. Health Officials Push for Looser Marijuana Restrictions: What You Need to Know"

The U.S. Department of Health and Human Services has requested the Drug Enforcement Agency (DEA) to consider loosening restrictions on marijuana by moving it from a Schedule I to a Schedule III drug classification. This could have significant implications for the cannabis industry, including new tax opportunities, potential for interstate commerce, expanded research, and increased investor interest. However, federal legalization and access to banking services for the industry still require further legislative action. The DEA is expected to make a decision before the 2024 presidential election.